<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Smooth Muscle Regulation - Section III.E</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            background: linear-gradient(135deg, #1e3c72 0%, #2a5298 100%);
            color: #2c3e50;
            padding: 20px;
            line-height: 1.6;
        }
        
        .container {
            max-width: 1400px;
            margin: 0 auto;
            background: white;
            border-radius: 15px;
            padding: 40px;
            box-shadow: 0 20px 60px rgba(0,0,0,0.2);
        }
        
        .header {
            text-align: center;
            margin-bottom: 30px;
            padding-bottom: 20px;
            border-bottom: 3px solid #1e3c72;
        }
        
        .header h1 {
            font-size: 2.5em;
            color: #1e3c72;
            margin-bottom: 10px;
            font-weight: 700;
        }
        
        .section-title {
            font-size: 1.8em;
            color: #1e3c72;
            margin: 30px 0 20px 0;
            font-weight: 600;
        }
        
        .clinical-box {
            background: #f0f8ff;
            border: 2px solid #4682b4;
            border-radius: 12px;
            padding: 25px;
            margin: 30px 0;
        }
        
        .clinical-box h3 {
            color: #1e3c72;
            font-size: 1.4em;
            margin-bottom: 15px;
            display: flex;
            align-items: center;
            gap: 10px;
        }
        
        .clinical-box p {
            line-height: 1.8;
            color: #34495e;
            text-align: justify;
        }
        
        .regulation-content {
            margin: 30px 0;
        }
        
        .regulation-content p {
            line-height: 1.8;
            margin-bottom: 15px;
            text-align: justify;
        }
        
        .regulation-item {
            background: #f8f9fa;
            border-left: 4px solid #3498db;
            padding: 20px;
            margin: 20px 0;
            border-radius: 8px;
        }
        
        .regulation-item h4 {
            color: #1e3c72;
            font-size: 1.3em;
            margin-bottom: 12px;
        }
        
        .highlight-box {
            background: linear-gradient(135deg, #fff3cd 0%, #ffeaa7 100%);
            border: 2px solid #ffc107;
            border-radius: 12px;
            padding: 20px;
            margin: 25px 0;
            text-align: center;
        }
        
        .highlight-box p {
            color: #856404;
            font-size: 1.1em;
            font-weight: 600;
        }
        
        .figure-container {
            background: #f8f9fa;
            border: 2px solid #dee2e6;
            border-radius: 12px;
            padding: 30px;
            margin: 30px 0;
            text-align: center;
        }
        
        .figure-title {
            font-size: 1.3em;
            color: #1e3c72;
            margin-bottom: 20px;
            font-weight: 600;
        }
        
        .control-buttons {
            display: flex;
            justify-content: center;
            gap: 15px;
            margin: 20px 0;
        }
        
        .btn {
            padding: 10px 25px;
            border: none;
            border-radius: 25px;
            font-size: 1em;
            font-weight: 600;
            cursor: pointer;
            transition: all 0.3s;
            color: white;
        }
        
        .btn-contract {
            background: linear-gradient(135deg, #e74c3c, #c0392b);
        }
        
        .btn-relax {
            background: linear-gradient(135deg, #27ae60, #229954);
        }
        
        .btn-reset {
            background: linear-gradient(135deg, #7f8c8d, #95a5a6);
        }
        
        .btn:hover {
            transform: translateY(-3px);
            box-shadow: 0 10px 25px rgba(0,0,0,0.2);
        }
        
        .key-point {
            background: #e8f5e9;
            border-left: 4px solid #4caf50;
            padding: 15px;
            margin: 20px 0;
            font-style: italic;
        }
        
        .abbreviation {
            color: #e74c3c;
            font-weight: 600;
        }
        
        @media (max-width: 768px) {
            .control-buttons {
                flex-direction: column;
                align-items: center;
            }
            
            .btn {
                min-width: 200px;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">
            <h1>III.E. Regulation of Smooth Muscle Contraction</h1>
        </div>

        <div class="regulation-content">
            <p>
                In striated muscle, force regulation usually occurs through control of intracellular Ca<sup>2+</sup> concentration. 
                In smooth muscle, force is regulated via changes in MLC<sub>20</sub> phosphorylation state. Force development 
                is dependent on crossbridge formation, which can only occur when MLC<sub>20</sub> is phosphorylated. Because 
                MLC<sub>20</sub> phosphorylation state is dependent on Ca<sup>2+</sup>, MLCK, and MLCP, there are multiple 
                potential control points. Three principal regulatory pathways involve <span class="abbreviation">ROCK</span> 
                (Rho-associated coiled-coil containing protein kinase, or Rho-kinase), <span class="abbreviation">protein kinase C (PKC)</span>, 
                and, in some tissues, <span class="abbreviation">protein kinase G (PKG)</span>, as shown in Figure 13.6.
            </p>
        </div>

        <div class="regulation-item">
            <h4>1. Rho-kinase (ROCK)</h4>
            <p>
                ROCK is a serine-threonine protein kinase regulated by RhoA, a G protein. RhoA is activated indirectly following 
                GPCR binding by, for example, norepinephrine, angiotensin II, endothelin, or any of a number of other ligands. 
                ROCK has several targets, including MYPT1. Phosphorylation inhibits MLCP and thereby promotes contraction. 
                ROCK also has MLCK-like activity and stimulates contraction through direct effects on MLC<sub>20</sub>. 
                Note that this pathway acts independently of any changes in sarcoplasmic Ca<sup>2+</sup> concentration.
            </p>
        </div>

        <div class="regulation-item">
            <h4>2. Protein kinase C (PKC)</h4>
            <p>
                Agonists that activate phospholipase C and promote contraction via IP<sub>3</sub> simultaneously activate PKC. 
                PKC also phosphorylates many proteins that regulate contraction, including CPI-17 (PKC-potentiated inhibitor 
                protein of 17 kDa). CPI-17 is an endogenous protein that binds to the PP1c MLCP catalytic domain and inhibits it, 
                thereby promoting contraction. ROCK also phosphorylates CPI-17 in vitro, but the possible significance for 
                smooth muscle function in vivo is unclear.
            </p>
        </div>

        <div class="highlight-box">
            <p>
                ROCK- and PKC-mediated contractility increases account for a phenomenon known as "Ca<sup>2+</sup> sensitization." 
                Ca<sup>2+</sup> sensitization refers to an observed shift in the Ca<sup>2+</sup> dependence of contractility 
                toward lower intracellular free Ca<sup>2+</sup> values following hormone or transmitter binding.
            </p>
        </div>

        <div class="regulation-item">
            <h4>3. Protein kinase G (PKG)</h4>
            <p>
                PKG is activated by cGMP, which is the product of guanylyl cyclase (GC). In vascular smooth muscle, 
                nitric oxide (NO) activates a soluble GC, which stimulates the activity of a PKG isoform common to 
                smooth muscle (PKG1α). PKG-1α binds to a carboxyterminal leucine zipper domain on MYPT1, activating it 
                and promoting smooth muscle relaxation. Expression of the PKG-sensitive MLCP may be limited to vascular 
                smooth muscle because NO has no effect on most other smooth muscle types.
            </p>
        </div>

        <div class="figure-container">
            <div class="figure-title">Figure 13.6: Pathways Regulating Smooth Muscle Contraction</div>
            
            <svg width="800" height="500" viewBox="0 0 800 500">
                <!-- Background -->
                <rect width="800" height="500" fill="#f8f9fa" rx="10"/>
                
                <!-- Title -->
                <text x="400" y="30" text-anchor="middle" font-size="18" font-weight="bold" fill="#1e3c72">
                    Smooth Muscle Contraction Regulation Pathways
                </text>
                
                <!-- Upper pathway boxes -->
                <!-- PKC -->
                <rect x="100" y="80" width="80" height="50" rx="8" fill="#ff9999" stroke="#cc0000" stroke-width="2"/>
                <text x="140" y="110" text-anchor="middle" font-size="14" font-weight="bold">PKC</text>
                
                <!-- RhoA -->
                <rect x="250" y="80" width="80" height="50" rx="8" fill="#ff9999" stroke="#cc0000" stroke-width="2"/>
                <text x="290" y="110" text-anchor="middle" font-size="14" font-weight="bold">RhoA</text>
                
                <!-- cGMP -->
                <rect x="400" y="80" width="80" height="50" rx="8" fill="#99ccff" stroke="#0066cc" stroke-width="2"/>
                <text x="440" y="110" text-anchor="middle" font-size="14" font-weight="bold">cGMP</text>
                
                <!-- NO arrow to cGMP -->
                <path d="M 440 60 L 440 80" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                <text x="460" y="70" font-size="12" fill="#666">NO</text>
                
                <!-- Plus signs -->
                <circle cx="140" cy="150" r="15" fill="#ffcc00" stroke="#ff9900" stroke-width="2"/>
                <text x="140" y="155" text-anchor="middle" font-size="16" font-weight="bold">+</text>
                
                <circle cx="290" cy="150" r="15" fill="#ffcc00" stroke="#ff9900" stroke-width="2"/>
                <text x="290" y="155" text-anchor="middle" font-size="16" font-weight="bold">+</text>
                
                <circle cx="440" cy="150" r="15" fill="#66ff66" stroke="#00cc00" stroke-width="2"/>
                <text x="440" y="155" text-anchor="middle" font-size="16" font-weight="bold">+</text>
                
                <!-- Middle pathway boxes -->
                <!-- CPI-17 -->
                <rect x="60" y="190" width="70" height="40" rx="6" fill="#ffcccc" stroke="#990000" stroke-width="2"/>
                <text x="95" y="215" text-anchor="middle" font-size="12">CPI-17</text>
                
                <!-- ROCK -->
                <rect x="255" y="190" width="70" height="40" rx="6" fill="#ffcccc" stroke="#990000" stroke-width="2"/>
                <text x="290" y="215" text-anchor="middle" font-size="12">ROCK</text>
                
                <!-- PKG1α -->
                <rect x="405" y="190" width="70" height="40" rx="6" fill="#ccffcc" stroke="#009900" stroke-width="2"/>
                <text x="440" y="215" text-anchor="middle" font-size="12">PKG1α</text>
                
                <!-- Minus signs -->
                <circle cx="95" cy="250" r="15" fill="#ff6666" stroke="#cc0000" stroke-width="2"/>
                <text x="95" y="255" text-anchor="middle" font-size="16" font-weight="bold">−</text>
                
                <circle cx="290" cy="250" r="15" fill="#ff6666" stroke="#cc0000" stroke-width="2"/>
                <text x="290" y="255" text-anchor="middle" font-size="16" font-weight="bold">−</text>
                
                <circle cx="440" cy="250" r="15" fill="#66ff66" stroke="#00cc00" stroke-width="2"/>
                <text x="440" y="255" text-anchor="middle" font-size="16" font-weight="bold">+</text>
                
                <!-- PP1c and MYPT1 -->
                <rect x="80" y="290" width="50" height="35" rx="5" fill="#e6e6ff" stroke="#6666cc" stroke-width="2"/>
                <text x="105" y="312" text-anchor="middle" font-size="11">PP1c</text>
                
                <rect x="260" y="290" width="60" height="35" rx="5" fill="#e6e6ff" stroke="#6666cc" stroke-width="2"/>
                <text x="290" y="312" text-anchor="middle" font-size="11">MYPT1</text>
                
                <text x="410" y="307" font-size="11" fill="#666">Leucine</text>
                <text x="410" y="320" font-size="11" fill="#666">zipper</text>
                
                <!-- MLCP -->
                <rect x="200" y="340" width="100" height="40" rx="8" fill="#ccccff" stroke="#6666cc" stroke-width="2"/>
                <text x="250" y="365" text-anchor="middle" font-size="14" font-weight="bold">MLCP</text>
                
                <!-- Myosin cycle -->
                <ellipse cx="550" cy="250" rx="80" ry="60" fill="none" stroke="#666" stroke-width="2" stroke-dasharray="5,5"/>
                
                <!-- Myosin boxes -->
                <rect x="510" y="200" width="80" height="30" rx="5" fill="#ffff99" stroke="#cccc00" stroke-width="2"/>
                <text x="550" y="220" text-anchor="middle" font-size="12">Myosin</text>
                
                <rect x="510" y="270" width="80" height="30" rx="5" fill="#ffff99" stroke="#cccc00" stroke-width="2"/>
                <text x="550" y="290" text-anchor="middle" font-size="12">Myosin-P</text>
                
                <!-- Phosphorylation/Dephosphorylation labels -->
                <text x="620" y="235" font-size="11" fill="#666">Phosphorylation</text>
                <text x="480" y="235" font-size="11" fill="#666">Dephosphorylation</text>
                
                <!-- CONTRACT/RELAX -->
                <rect x="480" y="380" width="140" height="50" rx="10" fill="#ff6666" stroke="#cc0000" stroke-width="3"/>
                <text x="550" y="410" text-anchor="middle" font-size="18" font-weight="bold" fill="white">CONTRACT</text>
                
                <!-- MLCK -->
                <rect x="380" y="420" width="80" height="40" rx="6" fill="#ff9999" stroke="#cc0000" stroke-width="2"/>
                <text x="420" y="445" text-anchor="middle" font-size="12" font-weight="bold">MLCK</text>
                
                <!-- Ca2+-CaM -->
                <rect x="280" y="420" width="80" height="40" rx="6" fill="#ffcc99" stroke="#ff9900" stroke-width="2"/>
                <text x="320" y="445" text-anchor="middle" font-size="12">Ca²⁺-CaM</text>
                
                <!-- Ca2+ -->
                <circle cx="200" cy="440" r="25" fill="#ffd700" stroke="#ffaa00" stroke-width="2"/>
                <text x="200" y="445" text-anchor="middle" font-size="12" font-weight="bold">Ca²⁺</text>
                
                <!-- Connecting arrows -->
                <path d="M 140 130 L 95 190" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                <path d="M 290 130 L 290 190" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                <path d="M 440 130 L 440 190" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                
                <path d="M 95 230 L 105 290" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                <path d="M 290 230 L 290 290" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                <path d="M 440 230 L 430 290" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                
                <path d="M 250 340 L 250 300" stroke="#666" stroke-width="2"/>
                <path d="M 300 360 L 470 280" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                
                <path d="M 225 440 L 280 440" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                <path d="M 360 440 L 380 440" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                <path d="M 460 440 L 510 400" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)"/>
                
                <!-- Arrow definition -->
                <defs>
                    <marker id="arrowhead" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                        <polygon points="0 0, 10 3, 0 6" fill="#666"/>
                    </marker>
                </defs>
                
                <!-- Plus sign in MLCK effect -->
                <circle cx="480" cy="355" r="12" fill="#ffcc00" stroke="#ff9900" stroke-width="2"/>
                <text x="480" y="360" text-anchor="middle" font-size="14" font-weight="bold">+</text>
            </svg>
            
            <div class="control-buttons">
                <button class="btn btn-contract" onclick="showContraction()">Show Contraction Pathway</button>
                <button class="btn btn-relax" onclick="showRelaxation()">Show Relaxation Pathway</button>
                <button class="btn btn-reset" onclick="resetPathways()">Reset</button>
            </div>
        </div>



        <div class="key-point">
            <strong>Key Point:</strong> MLCK = myosin light-chain kinase; MLCP = myosin light-chain phosphatase; 
            MYPT1 = MLCP myosin-binding subunit; NO = nitric oxide; PKC = protein kinase C; PKG-1α = protein kinase G1α; 
            PP1c = MLCP protein phosphatase subunit; ROCK = Rho-kinase.
        </div>
    </div>

    <script>
        function showContraction() {
            alert('Contraction Pathway:\nPKC/ROCK → CPI-17/MYPT1 inhibition → MLCP ↓ → Myosin-P ↑ → CONTRACTION\n\nCa²⁺ → CaM → MLCK → Myosin phosphorylation → CONTRACTION');
        }
        
        function showRelaxation() {
            alert('Relaxation Pathway:\nNO → cGMP → PKG1α → MYPT1 activation → MLCP ↑ → Myosin dephosphorylation → RELAXATION\n\nCa²⁺ ↓ → MLCK deactivation → MLCP dominance → RELAXATION');
        }
        
        function resetPathways() {
            alert('Smooth muscle contraction state depends on the balance between:\n• MLCK (phosphorylation) vs MLCP (dephosphorylation)\n• Ca²⁺ concentration\n• Regulatory kinases (ROCK, PKC, PKG)');
        }
    </script>
</body>
</html>